GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Change In Other Working Capital

Genenta Science SPA (Genenta Science SPA) Change In Other Working Capital : $0.60 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Change In Other Working Capital?

Genenta Science SPA's Change In Other Working Capital for the quarter that ended in Dec. 2023 was $1.24 Mil. It means Genenta Science SPA's Other Working Capital increased by $1.24 Mil from Jun. 2023 to Dec. 2023 .

Genenta Science SPA's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $0.59 Mil. It means Genenta Science SPA's Other Working Capital increased by $0.59 Mil from Dec. 2022 to Dec. 2023 .


Genenta Science SPA Change In Other Working Capital Historical Data

The historical data trend for Genenta Science SPA's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Change In Other Working Capital Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
-0.64 -0.24 -0.28 -0.22 0.59

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only -0.07 0.48 -0.69 -0.64 1.24

Genenta Science SPA Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genenta Science SPA Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Genenta Science SPA (Genenta Science SPA) Business Description

Industry
Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.